Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference
Adagio Medical (Nasdaq: ADGM) said management will present at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 10:30 a.m. ET at the Lotte Palace in New York.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Presentation Information
A live and recorded webcast of the presentation will be available at:
https://event.webcasts.com/starthere.jsp?ei=1742138&tp_key=f2a06e9abc
About Adagio Medical Holdings, Inc.
Adagio is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation (ULTC) technology. ULTC is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The Company is currently focused on the treatment of ventricular arrhythmias with its purpose-built vCLAS™ Cryoablation System, which is CE Marked and is currently under evaluation in the Company’s FULCRUM-VT
View source version on businesswire.com: https://www.businesswire.com/news/home/20251105837821/en/
Debbie Kaster
Chief Financial Officer and Chief Business Officer
dkaster@adagiomedical.com
Source: Adagio Medical Holdings, Inc.